ClinVar Miner

Submissions for variant NM_001130987.2(DYSF):c.2011G>A (p.Gly671Ser)

gnomAD frequency: 0.00006  dbSNP: rs538170367
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000348203 SCV000335626 uncertain significance not provided 2015-09-22 criteria provided, single submitter clinical testing
Invitae RCV001466761 SCV001670770 likely benign Qualitative or quantitative defects of dysferlin 2023-12-26 criteria provided, single submitter clinical testing
Neuberg Centre For Genomic Medicine, NCGM RCV001823130 SCV002073026 uncertain significance Autosomal recessive limb-girdle muscular dystrophy type 2B criteria provided, single submitter clinical testing The missense variant p.G653S in DYSF (NM_003494.4) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The variant has been submitted to ClinVar as Uncertain Significance. The p.G653S variant is observed in 14/30,534 (0.0459%) alleles from individuals of South Asian background in gnomAD Exomes and in 2/978 (0.2045%) alleles from individuals of South Asian background in 1000 Genomes. The p.G653S missense variant is predicted to be damaging by both SIFT and PolyPhen2. The nucleotide c.1957 in DYSF is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.